AZOR 5-20 MG TABLET

amlodipine besylate and olmesartan medoxomil
$12.8138per EA

Strength

5; 20 mg/1; mg/1

NDC

00713087030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA022100

On Market Since

9/1/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.3%

3Y

N/A

5Y

N/A

All

+9.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.